finance.yahoo.comAclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conferenceover 1 year ago
finance.yahoo.comAclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimatesover 1 year ago
finance.yahoo.comAclaris Therapeutics Second Quarter 2024 Earnings: Beats Expectationsover 1 year ago
benzinga.comAclaris Therapeutics Announces Sale of OLUMIANT Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Millionover 1 year ago
benzinga.comAclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenceover 1 year ago